Similarly, Zhang et al., (2014) showed that the anti-tumor effects of PA-MSHA could be linked to the activation of immune cells, mainly cytokine-induced killer (CIK) cells, and the downregulation of inhibitory cell surface markers, such as PD-1 and CTLA-4, expressed on effector T cells [53]. Here, CTLA4 is linked to neoplasm.